PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

42,576 stories, page 527 of 710

Advanced search
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Request for Information, Training and Care Delivery Models for Safe Administration of Potential FDA-Approved Psychedelic Therapies in Ambulatory Clinical Settings

On April 18, 2026, President Trump issued Executive Order (E.O.) 14401, "Accelerating Medical Treatm...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Shane Lydon, M.D.; Decision and Order

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Barlow St-Clair Lynch, M.D.; Decision and Order

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

David Enright, M.D.; Decision and Order

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Government-Owned Inventions; Availability for Licensing

The National Institute of Allergy and Infectious Diseases (NIAID), an institute of the National Inst...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Designated Placement Requirements Under Titles IV-E and IV-B for LGBTQI+ Children; Rescission

This rule finalizes the removal of the requirements issued in the Designated Placement Requirements...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Formal Meetings Between FDA and Sponsors or Requestors of Over-the-Counter Monograph Drugs

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Topical Dermatologic Corticosteroids: In Vivo Bioequivalence; Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

National Vaccine Injury Compensation Program; List of Petitions Received

HRSA is publishing this notice of petitions received under the National Vaccine Injury Compensation...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Federal Register Notice: Change in Eligibility Period for Refugee Cash Assistance and Refugee Medical Assistance

The Office of Refugee Resettlement (ORR) announces a change to the eligibility period for Refugee Ca...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities: Submission for OMB Review; Comment Request

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to co...

Federal RegisterOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Loxapine

Official structured record identifier: 2d45dd3c-71c3-4cc1-92ac-6dcecb195dd2.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Olanzapine

Official structured record identifier: 2a7300d3-95e3-427e-bf37-55fa654cc90a.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Mirtazapine

Official structured record identifier: 2a0689ae-5650-42d1-ac9d-56dd2b467727.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Calcipotriene

Official structured record identifier: 277d843a-0ea9-429d-813d-49ed72dafb64.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Cyproheptadine Hydrochloride

Official structured record identifier: 1d668d93-8c9e-479e-ad8d-59656c8dec1b.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Clotrimazole and Betamethasone Dipropionate

Official structured record identifier: 1c18e5fc-bf82-47bc-bfd9-8d3e503569ba.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Haloperidol Decanoate

Official structured record identifier: 1a0e38cb-fd9f-4962-9f81-5c0023ca6b4c.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Zinc Oxide Perfecting Sunscreen

Official structured record identifier: 1a0228f9-bf3f-a1fe-e063-6294a90a3fb5.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Sodium Sulfacetamide 10 Sulfur 5 Cleanser

Official structured record identifier: 1926eadd-d11f-44fa-971f-0041060f7589.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Kirkland Signature Quit 2

Official structured record identifier: 17f17eb6-ebc3-4a71-9f1b-41e2b5dcf6c1.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: POTASSIUM CITRATE

Official structured record identifier: 164d9d05-fbb1-4d99-8ba3-ff9c172aa8ca.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Vacation Face

Official structured record identifier: 14b8a3cf-031c-4c52-ba81-e683e69d0f37.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Childrens Loratadine

Official structured record identifier: 12c8066a-3429-481e-b63a-7ea2b439a170.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Cephalexin

Official structured record identifier: 11cfefee-d75e-430c-8817-02dc57de0e88.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: terrasil Antifungal Cleansing Bar

Official structured record identifier: 10a4fde0-87e1-4474-bcb5-255b0a7f1ecb.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Cough and Cold HBP

Official structured record identifier: 0fad61d8-4393-47ec-9ff6-7df5be761f5b.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Carvedilol

Official structured record identifier: 0e98593a-8424-48c8-acc0-671f4b566aee.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Rosuvastatin Calcium

Official structured record identifier: 0c919fc0-a3d7-4afb-968b-4ef0e447001c.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: EXXUA

Official structured record identifier: 0c78edd8-6acb-433c-9d34-2527da8d64e1.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Nystop

Official structured record identifier: 0bb31239-fb77-442a-a9ee-ba61b45e7e68.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Modafinil

Official structured record identifier: 013450dd-cd42-46c7-98d6-9a2925761978.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Remedy Barrier Cream Cloths Fragrance Free

Official structured record identifier: 00e0cd4a-6049-408a-ab3f-9edf97e6438a.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: unspecified product

Official structured record identifier: 00b35b4e-848b-4477-a735-2f88a16af9ef.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Trazodone Hydrochloride

Official structured record identifier: 007f38e0-653b-43e4-a1c1-b59997b2762a.

openFDA Drug LabelsOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Dexamethasone Alone versus Combined with Droperidol for Preventing Postoperative Nausea and Vomiting in Gynecological Day Surgery Under Ciprofol-Alfentanil Anesthesia: A Randomized Double-Blind Controlled Trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Perioperative Butorphanol for the Prevention of Postoperative Pulmonary Complications After Thoracoscopic Lung Resection: A Randomized, Double-Blind, Placebo-Controlled Trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Safety, pharmacokinetics and pharmacodynamics of TQC3721, an innovative, dual PDE3 and PDE4 inhibitor, in healthy subjects and patients with chronic obstructive pulmonary disease: Randomised, double-blind, placebo-controlled phase I and IIa clinical trials.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

JAK Inhibitors in Inflammatory Skin Diseases: A 15,427-Patient Systematic Review and Meta-analysis of Clinical Trial and Real-World Outcomes.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Eggshell powder as a biomimetic alternative to biodentine in primary teeth pulpotomy: a comparative clinical and radiographic study.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Analysis of FDA approvals, delays and denials of new drug applications, 2013-2023.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Intensified multifactorial intervention leads to long-term benefit on kidney outcomes in advanced diabetic kidney disease: A 10-year follow-up of the DNETT-Japan trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

A Randomized Trial Comparing Potato Poultice Compress Versus Traditional Medicated Compress for Forearm Swelling After Trans-Radial Percutaneous Coronary Intervention.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Randomized, Double-Blind, Placebo-Controlled First-in-Human Trial of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV-2 Spike S2 Stem Helix.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Nonparametric testing methods based on relative effect in non-inferiority clinical trial with multiple experimental drugs.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Drawing a line in the sand: impact of analytical choices on anti-drug antibody cut-points and testing outcomes.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

The internalising blind spot in ADHD pharmacotherapy research.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Investigating the effectiveness of N-acetyl cysteine mouthwash in preventing chemotherapy-induced oral mucositis: a randomized, double-blind controlled trial.

Europe PMCOriginal source
🌍Researchdoi.orgTier 1 · Research record

Comparative Effectiveness of Glucagon-like Peptide-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Persistence of a Right Ovarian Ectopic Pregnancy Following Failure of the Intrauterine Component of a Spontaneous Heterotopic Pregnancy: A Rare Case Report

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Elevated Serum Endocan Concentrations in People with Type 2 Diabetes and Diabetic Retinopathy

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Special articles: Controversies in cardio-rheumatology

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Neuroinflammatory mechanisms and immunomodulatory therapies in Alzheimer's disease

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Clinical, Radiological, and Functional Outcomes of Open Long Bone Fractures Treated Primarily with the Limb Reconstruction System: A Prospective Observational Study

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Antibacteria Potential of Urtica Dioica Leaf Extract Against Selected Clinical Bacterial Isolates

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Life autobiography – death autobiography

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Present and current/actual

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Rituals and repetitions

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

The shadow zone

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Introduction

CrossrefOriginal source